<img src="https://ml.globenewswire.com/Resource/Download/348e95f7-f41b-461f-94c6-c663f05170e8?size=2" nborder="0" align="left" hspace="5" vspace="5" title="NuTek_logo_RGB@4x.jpg" alt="Nu-Tek Biosciences, LLC"/><div style="float:right;padding:0 0 15px 20px;margin:15px 0 20px 20px;width:300px">
  <p>Nu-Tek Facility</p>
  <figure>
    <img src="https://ml.globenewswire.com/Resource/Download/49fd9c5c-4c3c-40ce-85a7-d468c337c6d2" title="Nu-Tek Facility" alt="Nu-Tek's state-of-the-art facility in Austin, Minnesota." />
    <figcaption>Nu-Tek's state-of-the-art facility in Austin, Minnesota.</figcaption>
  </figure>
</div><div style="float:right;padding:0 0 15px 20px;margin:15px 0 20px 20px">
  <div style="float:left;margin:10px 0 0 0;border:#ddd 1px solid">
    <div style="float:left;padding:3px 3px 0 3px;margin:5px 5px 0 0">
      <iframe type="text/html" width="560" height="315" frameborder="0" allowfullscreen="" src="https://www.youtube.com/embed/THkWBiJ-80I" title="Experience Nu-Tek's state-of-the-art animal-free production facility, located in Austin, Minnesota."></iframe>
    </div>
    <p />
    <div style="float:left;margin:10px 0 0 0" />
    <h5>Experience Nu-Tek's state-of-the-art animal-free production facility, located in Austin, Minnesota. </h5>
  </div>
</div><ul><li>Nu-Tek will engage pharmaceutical stakeholders at CPHI Global, Oct. 6-8 in Milan, to discuss its 100% animal-free peptones and protein hydrolysates that support cell culture media qualification while strengthening supply security and development efficiency.<br /><br /></li></ul>  <p>MINNETONKA, Minn., Sept.  03, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- Nu-Tek BioSciences, the leader in 100% animal-origin-free (AOF) peptones and protein hydrolysates, will meet with biotech experts at CPHI Global 2026, taking place October 6-8, 2026, in Milan, Italy. Nu-Tek will host in-depth discussions with key stakeholders responsible for sourcing, qualifying and purchasing raw materials for cell culture media, with a focus on quality, consistency, and regulatory-friendly supply.</p>  <p>Nu-Tek will highlight it’s animal-free raw materials portfolio, relied upon by global pharmaceutical manufacturers to support cell culture and microbial fermentation applications used in the production of vaccines, therapeutics, and other biologics. The company’s products are purposefully designed to be customizable, with an emphasis on reducing development risk, improving supply continuity, and strengthening confidence in upstream raw material selection.</p>  <p>“The pharmaceutical industry’s media needs are evolving,” says Chris Weidel, Nu-Tek’s Chief Business Officer. “Companies are looking for animal-free, high quality, secure raw materials to build or enhance culture media productivity as a strategic advantage in the market. Nu-Tek delivers exactly what biopharmaceutical manufacturers are pushing for to meet their regulatory requirements and bioprocessing goals.”</p>  <p>Attendees can <a href="https://www.globenewswire.com/Tracker?data=op24SxpOoTWQl7RlyYLVNu4fu8ADuvf9M74W7xQvgi1BSXHnJVatMNoHu1XEfHqC81TIr3-0YBsFXVRh_sHApBFMM-SEm-zPxfUdHW1CIgg3ydyIhhI4-WXKlHG33TYun1aaVl0rDjFS__Xz4a_0Mlo0KJAAd0qZ_PlnEVJNucVpCMkbM0UsFfpUiOurQVeh" rel="nofollow" target="_blank" title="schedule a meeting">schedule a meeting</a> with Nu-Tek to discuss culture media needs during the show. Pharmaceutical teams looking to qualify alternative sources, improve media performance, or explore animal-free ingredient strategies are encouraged to connect in Milan.</p>  <p><strong>About Nu-Tek BioSciences</strong></p>  <p>Nu-Tek BioSciences is the market leader in the development and manufacturing of high-quality, 100% animal-origin-free (AOF) peptones and protein hydrolysates. Headquartered in Minnetonka, Minnesota, the company operates a state-of-the-art, purpose-built manufacturing facility dedicated to producing superior raw materials for the biopharmaceutical industry. Nu-Tek's innovative solutions are essential for cell culture and microbial fermentation, supporting the production of vaccines, therapeutics, and other vital biologics. More product information is available at <a href="https://www.globenewswire.com/Tracker?data=agdUgGveqQswHQR8brkysi4MpYJ0THOFY4AmzG8DHn9TYbbIpVFeT86_BFYa24ZbxjAwyDdDYKDiRpDhM6McXt9Ce0tXnY4nQX1YTFpU6bNpwXFx9UWSNP63jWJ7UQ0X" rel="nofollow" target="_blank" title="www.nu-tekbiosciences.com">www.nu-tekbiosciences.com</a>.</p>  <p><strong>Media Contact:</strong><br />Courtney Jones<br />Director of Commercial Development<br /><a href="https://www.globenewswire.com/Tracker?data=gIA6g0faOk0idZcdbnSB2SkOzmlOTZuN9fg5hU7fIDmEPTl_c5IsDJU5ooK7u_OFP9m78lDQ-z5m2Y9z16kuD4QP2UXiqsMuaXsS07KGhBR7zXJRCW3FpXvj3_0TAKtS" rel="nofollow" target="_blank" title="cjones@nu-tekbioscience.com">cjones@nu-tekbioscience.com</a><br />+1 (952) 936.3614<br /><a href="https://www.globenewswire.com/Tracker?data=agdUgGveqQswHQR8brkysi4MpYJ0THOFY4AmzG8DHn-4gQ8wDw0FU3lDDsh3ghnj06d2-TpmRU1i1DKR6tcoz--5Gbpdvvof3tzT15pA81NdWMFqQbpfbNuw4uEx2Hxp" rel="nofollow" target="_blank" title="www.nu-tekbiosciences.com">www.nu-tekbiosciences.com</a></p>  <p>A photo accompanying this announcement is available at: <a href="https://www.globenewswire.com/Tracker?data=Z2JJXyibl2sdMvdHt_360fBRTw2-Avs7TJtqTMlNR8kanRN5JFWoPB3gRuq8P-rdYsdVEQSlNyIqkMh3Ge5XaeOLGKJI6nq0a78WwrWXh1BKUDrgoJOOjkAuhpAEfXXlmKY4nqaPUXauQb1yuTLR3ka-XVPeON64EfY6-A0t1BansAdoncGJzn4Izfa__fMFh1h10bM1WBr1n3E4Ps1-VBxkATRw5HmttD4ljOQiyt2vZK0qMEt3NsdYhlmmPsRC3E8d9H04Y2J175IR7XPJaQ==" rel="nofollow" target="_blank" title="">https://www.globenewswire.com/NewsRoom/AttachmentNg/49fd9c5c-4c3c-40ce-85a7-d468c337c6d2</a></p>  <p>A video accompanying this announcement is available at: <a href="https://www.globenewswire.com/Tracker?data=Z2JJXyibl2sdMvdHt_360fBRTw2-Avs7TJtqTMlNR8kanRN5JFWoPB3gRuq8P-rdBlR97FYQiTW4M8Wz1PifmHiCxLBEP8SV-BMt3ybaJ3nb6D0beE-RBsQHauwn1GazxgMb9gjlztC0rg5vpYDkhgDuiYmccoyq3VukHLWI0ScgiIktJXCZhTJd8x0iKY5lpNUlQTm0sMikdeUnSFMNgZ8JQ6h6YkAHsjutyGNW_hkcI4-E94u9_fB7MUH0qinEZFzdw_7zsJRThYkslnv_qQ==" rel="nofollow" target="_blank" title="">https://www.globenewswire.com/NewsRoom/AttachmentNg/fedcbcbd-922c-4f03-a8e2-e60511df6e9d</a></p>  <br /><img alt="" src='https://ml.globenewswire.com/media/ZDc4MzIzYTctNTY3NS00OWIwLThhZGQtNmEyZDlkMjUzN2NhLTEzMTYyMDQtMjAyNi0wOS0wMy1lbg==/tiny/Nu-Tek-Biosciences-LLC.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Nu-Tek BioSciences’ Animal-Free Raw Materials Drive Cell Culture Media Evolution, Supply Security at CPHI Global 2026 in Milan

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn